Ben R. Taylor, CFO: Recursion Pharmaceuticals RXRX Sell · Filed 03/18

Trade details

Type: Insider sale
Amount: $26,970.84
Shares · price: 7,956 sh · $3.39 a share
Held after: 1,180,318 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Ben R. TaylorCFO
Trade date: 26/03/17
Filed: 26/03/18
Days to filing: 1 days

Sold 0.7% of holdings

Share of holding sold: 0.7%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/15~04/16

Ben R. Taylor's recent trades

Ben R. TaylorCFO
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$27K
7,956 sh
$27K
Filed 03/17
Traded 03/17
Ben R. TaylorCFO
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$41.4K
13,426 sh
$41.4K
Filed 02/19
Traded 02/18
Ben R. TaylorCFO
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$41.4K
13,426 sh
$41.4K
Filed 02/18
Traded 02/18
Ben R. TaylorCFO
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$89.4K
21,383 sh
$89.4K
Filed 25/12/30
Traded 25/12/29
Ben R. TaylorCFO
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$89.4K
21,383 sh
$89.4K
Filed 25/12/29
Traded 25/12/29